P53 MUTATIONAL STATUS AND SURVIVAL OF HUMAN BREAST-CANCER MCF-7 CELL VARIANTS AFTER EXPOSURE TO X-RAYS OR FISSION NEUTRONS
P53 MUTATIONAL STATUS AND SURVIVAL OF HUMAN BREAST-CANCER MCF-7 CELL VARIANTS AFTER EXPOSURE TO X-RAYS OR FISSION NEUTRONS
复制标题
DOI:
10.2307/3579133
复制
发表时间:
1995-06-01
影响因子:
3.4
通讯作者:
MELTZER, SJ
中科院分区:
文献类型:
--
作者:
BALCERKUBICZEK, EK;YIN, J;MELTZER, SJ
We assessed cytotoxicity of X rays or fission neutrons and the status of the p53 tumor suppressor gene in irradiated and unirradiated actively growing cultures of human breast cancer MCF-7 cells. One parental or wild-type (WT) and the other resistant to adriamycin (ADR(R)) were studied within the same experiment. We found that, relative to MCF-7 WT cells, MCF-7 ADR(R) cells exhibited a small but significant resistance to X rays, but not to fission neutrons. Single-strand conformation polymorphism analysis followed by DNA sequencing and immunohistochemical staining with a p53 protein-specific antibody performed on pooled polyclonal or monoclonal populations of MCF-7 WT or ADR(R) cells confirmed that wild-type cells have two normal copies of the p53 gene. We discovered p53 loss of heterozygosity and a point mutation in the remaining allele of the p53 gene in adriamycin-resistant cells. This mutation is a splice acceptor site change on the upstream border of exon 5 and results in p53 protein overexpression. No new p53 mutations were observed in MCF-7 WT or ADR(R) cells surviving either X or fission-neutron irradiations. Our results suggest that the mutant p53 allele affects cytotoxic outcomes of DNA damage from X rays but not from neutrons. (C) 1995 by Radiation Research Society